CYP2A13 and urinary bladder cancer: Since smoking is the predominant risk factor for bladder cancer [17,44], the appropriate inhibition of CYP2A13 might stop the metabolism of some aromatic amines from smoke (e.g., 4-aminobiphenyl) that is metabolized by CYP2A13 into the ultimate carcinogens [11].